Recent Updates — FMC

FMC Corporation reported third-quarter 2026 revenue of $106 million, a decline of approximately 80% from the prior year period, driven by a $639 million negative impact from commercial actions to address elevated channel inventory and weaker demand. The company posted a consolidated GAAP net loss of $2.07 billion, or $15.54 per diluted share, compared to a net loss of $569 million in the prior-year period. Adjusted EBITDA was negative $559 million, including a $672 million charge from these commercial actions. FMC revised its full-year 2026 outlook, now expecting free cash flow between negative $350 million and negative $150 million, down from previous estimates. The company also lowered fourth-quarter revenue guidance to a range of $1.04 billion to $1.14 billion. FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel through innovative crop protection solutions.

FMC Corporation appointed Luc Tack, the Investor’s nominee, as a director effective October 21, 2026. This action fulfills an obligation under an Investor Agreement entered into at the closing of a Stock Purchase Agreement on September 23, 2026. Under that agreement, Tessenderlo Group NV purchased 30,319,166 shares of FMC common stock for $403.2 million at $13.30 per share. The Board size increased from nine to ten directors to accommodate the vacancy. Mr. Tack serves as CEO of Tessenderlo and will receive standard non-employee director compensation in cash rather than restricted stock units due to ownership restrictions. FMC Corporation operates in the agricultural sciences industry, developing crop protection products.

FMC Corporation entered into Amendment No. 8 to its Fifth Amended and Restated Credit Agreement, requiring the company to apply net cash proceeds from the previously announced sale of its commercial business in India toward repaying debt under the facility or for general corporate purposes. The amendment also conditionally releases certain guarantors and assets from security interests to facilitate actions ahead of the transaction. FMC Corporation operates in the agriculture industry, developing crop protection products.

FMC Corporation revised its third-quarter 2026 expectations downward, citing weaker-than-anticipated demand and elevated channel inventory levels. The company now projects Q3 revenue between $65 million and $125 million, with Adjusted EBITDA expected to range from negative $565 million to negative $510 million. These estimates include approximately $625 million to $675 million in charges related to comprehensive commercial actions designed to lower prices for select products held by channel customers and modify the U.S. selling model. FMC intends to report full quarterly results on October 29, 2026, and will provide preliminary outlooks for 2027 and 2028 on its earnings call on October 30, 2026. The company operates in the agricultural sciences industry, developing crop protection solutions including herbicides, insecticides, fungicides, and biologicals.

FMC Corporation completed the sale of 30,319,166 shares of common stock to Tessenderlo Group NV at $13.30 per share for an aggregate purchase price of approximately $403 million. Following this transaction, Tessenderlo Group holds approximately 20.0% of FMC's outstanding shares. Concurrently, the parties entered into an Investor Agreement and a Registration Rights Agreement. Under the Investor Agreement, Tessenderlo Group has the right to nominate one independent director to FMC's Board of Directors and appointed Luc Tack as its initial nominee. The agreement includes customary standstill restrictions, a three-year lock-up period for the shares, preemptive rights for Tessenderlo Group, and voting agreements. FMC Corporation operates in the agricultural sciences industry, developing crop protection solutions including herbicides, insecticides, and fungicides.

FMC Corporation reported second quarter 2026 results with revenue of $867 million, a 17 percent decline from the prior year period. The company posted a GAAP net loss of $187 million, or $1.49 per diluted share, compared to a profit in Q2 2025. Adjusted EBITDA fell 26 percent to $153 million, while adjusted EPS declined 62 percent to $0.26. FMC updated its full-year outlook, lowering revenue guidance to $3.50 billion–$3.70 billion and Adjusted EBITDA to $620 million–$680 million due to a challenging macro environment. Strategic actions included signing agreements to sell the India commercial business for $252 million, license rimisoxafen for a $200 million upfront payment, execute a sale-leaseback of its Newark property for $114 million, and secure a $400 million equity investment from Tessenderlo Group. These initiatives aim to generate approximately $1 billion in proceeds for debt reduction. FMC Corporation is a global agricultural sciences company providing crop protection solutions.